Loading page…

Arunjyoti Bio Ventures Ltd (PASURA) · mywealthgrid

About

Arunjyoti Bio Ventures Ltd operates in Other Financial Services within the Financials sector.

Face value: ₹1

Market cap

₹75 Cr

P/E

—

P/B

2.6×

Dividend yield

ROE

-14.9%

ROCE

-0.8%

Debt / equity

0.76

OPM

10.4%

EPS (TTM)

₹-0.1

Book value

₹1.5

52-week high

₹12.4

52-week low

₹3.9

₹4.0-67.4%1Y

Beta

1.53

Amplifies index moves

Volatility (1y)

53.6%

Annualised, daily returns

RSI (14)

45.8

Neither overbought nor oversold

Rel. strength (1y)

-75%

Behind the market

Beta is measured against NIFTY 50 over three years of weekly returns — 1 moves with the index, above 1 amplifies it, below 1 damps it.

Quick read

rule-based

Pros

+Revenue CAGR of 38.2% over the last 5 years

Cons

−Low return on equity of -14.5% (3-yr avg)
−Weak interest coverage of -0.2×
−Trading 67.6% below its 52-week high

Research score

Structured signal from quality, growth, valuation and momentum.

30/100

Business quality: 16
Growth: 33
Valuation: 69
Momentum

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Crisil LimitedCRISILCRISIL	₹31,943 Cr	₹31,943 Cr	₹4,310 Cr	₹1,268 Cr	29.7%	₹896 Cr	21%	33.9%	27.4%	48
RRP Semiconductor LtdRRPRRP	₹10,831 Cr	₹10,837 Cr	₹-7 Cr	₹-7 Cr	—	₹-8 Cr	—	-32.7%	-59.8%	—
Onemi Technology Solutions LimitedKISSHTKISSHT	₹5,959 Cr	₹7,051 Cr	₹2,179 Cr	₹651 Cr	29.9%	₹281 Cr	12.9%	32.9%	21%	-8
Asset Reconstruction Company (India) LimitedARCILARCIL	₹4,073 Cr	₹5,278 Cr	₹722 Cr	₹473 Cr	65.5%	₹-36 Cr	44.7%	—	-1.3%	—
Colab Platforms LtdCOLABCOLAB	₹2,472 Cr	₹2,474 Cr	₹158 Cr	₹2 Cr	1%	₹5 Cr	2.9%	23.2%	17.2%	9
Gyftr LtdGYFTRGYFTR	₹1,649 Cr	₹1,685 Cr	₹14 Cr	₹3 Cr	21.6%	₹2 Cr	12.9%	—	0.5%	—
Prime Securities LimitedPRIMESECUPRIMESECU	₹1,036 Cr	₹1,038 Cr	₹125 Cr	₹13 Cr	15.7%	₹5 Cr	9.6%	—	6.7%	—
Centrum Capital LimitedCENTRUMCENTRUM	₹931 Cr	₹16,988 Cr	₹3,643 Cr	₹948 Cr	29.2%	₹-217 Cr	-7.5%	12.7%	-46.8%	-519
Wealth First Portfolio Managers LimitedWEALTHWEALTH	₹876 Cr	₹876 Cr	₹53 Cr	₹29 Cr	72.3%	₹28 Cr	56%	34.5%	27.7%	563
Regency Fincorp LtdREGENCYREGENCY	₹521 Cr	₹616 Cr	₹2 Cr	₹1 Cr	78.1%	₹0 Cr	12.9%	—	6.2%	—
The Investment Trust Of India LimitedTHEINVESTTHEINVEST	₹454 Cr	₹505 Cr	₹247 Cr	₹34 Cr	20.2%	₹32 Cr	12.2%	8.5%	4.2%	-42
Stellant Securities (India) LtdSTELLANTSTELLANT	₹390 Cr	₹390 Cr	₹0 Cr	₹-0 Cr	-93.8%	₹-0 Cr	-93.8%	-45.5%	-44.8%	0

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	—	39	—	—	7	6	3	2	20	28	28
Interest	—	—	—	—	—	0	0	0	2	3	2
Expenses	0	39	0	4	7	5	3	2	18	23	25
Financing profit	—	—	—	—	—	0	-0	0	1	2	1
Financing margin %	—	—	—	—	—	1.6%	-6.7%	9.2%	3.3%	8.7%	3%
Other income	—	—	—	—	—	0	0	0	0	0	0
Depreciation	0	0	0	—	—	0	0	0	2	3	3
Exceptional items	—	—	—	—	—	—	—	—	0	0	-3
Profit before tax	-0	0	-0	0	0	0	0	0	-1	-0	-5
Tax	—	0	—	—	—	0	0	0	-1	1	-1
Tax %	—	16.7%	—	—	—	22.2%	25%	25%	-73.1%	435.3%	-11.7%
PAT	-0	0	-0	0	0	0	0	0	-0	-2	-5
EPS (₹)	—	1	-1.2	0.2	0.5	0.3	—	—	-1.7	-0.1	-0.2
EPS adjusted (₹)	—	—	—	—	—	0	0	0.1	-0.2	-0.1	-0.2
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	2	2	2	2	19	19
Reserves	-0	-0	0	-0	14	10
Minority interest	0	—	0	—	—	—
	0	0	32	51	26	22
	3	0	2	1	2	4
Total equity & liabilities	5	2	36	54	60	54
	0	0	0	41	43	42
CWIP	0	0	19	—	0	0
Investments	0	0	0	0	2	3
	5	2	17	13	15	9
Total assets	5	2	36	54	60	54

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-0	-1	-13	6	1	10
	0	0	-19	-23	-6	-5
	0	0	32	17	5	-6
Net cash flow	-0	-1	0	0	1	-0
Free cash flow	—	—	-32	-17	-4	7
CFO / Operating profit %	-344.4%	—	—	228.6%	28.9%	359.7%

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Standalone figures

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	—	—	15.2%	3.4%	13.8%	58.3%	81.2%	—
EBITDA margin %	—	1.6%	1.6%	-6.7%	9.2%	13.5%	18%	10.4%
EBIT margin %	—	1.6%	1.6%	-6.7%	9.2%	3.7%	7%	-1.7%
PAT margin %	—	1.5%	1.3%	2%	6.9%	-1.7%	-6.5%	-16.4%
Working capital
Receivable days	—	—	122	66	164	49	52	51
Inventory days	—	—	2	0	214	126	183	2
Payable days	—	—	102	3	0	17	0	26
NWC days	—	—	22	64	378	158	235	26
Leverage
Current ratio	—	—	1.16	12.11	3.64	1.51	2.8	0.43
Debt to EBITDA	—	—	0	—	201.69	18.39	5.11	7.55
Debt to equity	—	—	0	0	15.29	28.67	0.79	0.76
Interest coverage	—	—	—	—	—	0.4	0.9	-0.2
Asset turnover	—	—	1.17	1.41	0.05	0.38	0.47	0.51
Return ratios
Return on assets %	—	—	1.5%	2.9%	0.3%	-0.6%	-3.1%	-8.4%
Return on capital employed %	—	—	4.6%	4.1%	0.9%	2%	4.4%	-0.8%
Return on equity %	—	—	3.6%	3%	5.7%	-19.8%	-5.6%	-15.8%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
	48.97%	61.79%	61.79%	61.79%	61.05%	47.64%	47.64%	47.64%	47.64%	47.64%	47.64%	47.64%
FII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
DII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	51.03%	38.21%	38.21%	38.21%	38.95%	52.36%	52.36%	52.36%	52.36%	52.36%	52.36%	52.36%
No. of shareholders	—	—	—	—	—	—	—	5,321	5,215	5,634	20,483	18,520

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Arunjyoti Bio Ventures Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Annual reports

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Face value ₹10 → ₹117 Jan 2025 · ex-date

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

42 announcementsExport CSV

13 May 2026, 6:14 pmResult

Audited Financial Statements For The Quarter And Year Ended 31.03.2026

Financial Results PDF

12 May 2026, 2:50 pmCompany Update

Board Meeting Intimation for Postponement Of Board Meeting Scheduled To Be Held On 12.05.2026 To 13.05.2026

Board Meeting Rescheduled PDF

5 May 2026, 2:57 pmCompany Update

Board Meeting Intimation for Postponement Of Board Meeting Scheduled To Be Held On 08.05.2026 To 12.05.2026.

Board Meeting Rescheduled PDF

1 May 2026, 4:42 pmBoard Meeting

Board Meeting Intimation for Board Meeting To Be Held On 08.05.2026.

Exchange filing PDF

30 Apr 2026, 4:50 pmOthers

Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2 PDF

30 Apr 2026, 4:44 pmOthers

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A PDF

17 Apr 2026, 10:28 amInsider Trading / SAST

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 PDF

13 Apr 2026, 6:44 pmCompany Update

Clarification In Trading Of The Shares Of The Company.

General PDF

Date	Category	Subject	Filing
13 May 2026, 6:14 pm	Result Financial Results	Audited Financial Statements For The Quarter And Year Ended 31.03.2026	PDF
12 May 2026, 2:50 pm	Company Update Board Meeting Rescheduled	Board Meeting Intimation for Postponement Of Board Meeting Scheduled To Be Held On 12.05.2026 To 13.05.2026

Loading announcements…

50 deals · 25 May 2022 – 16 Apr 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
16 Apr 2026	CHENNUPATI SARATH KUMAR	Bulk	BSE	Sell	23,79,657	₹10.59	₹2.52 Cr
15 Apr 2026	CHENNUPATI SARATH KUMAR	Bulk	BSE	Sell	23,63,351	₹10.18	₹2.41 Cr
9 Apr 2026	CHENNUPATI SARATH KUMAR	Bulk	BSE	Sell	11,58,401	₹8.83	₹1.02 Cr
29 Aug 2025	SHASHANK SAI PABBATHI	Bulk	BSE	Buy	45,90,000	₹6.00	₹2.75 Cr
29 Aug 2025	MONIKA UDAY SHAH	Bulk	BSE	Sell	45,87,616	₹6.00	₹2.75 Cr
13 Dec 2024	P BADARI NARAYANA	Bulk	BSE	Sell	1,38,000	₹165.20	₹2.28 Cr
29 Apr 2024	AMIT DHANYAKUMAR CHORDIA	Bulk	BSE	Buy	1,53,000	₹64.99	₹0.99 Cr
29 Apr 2024	GLADISMENEZES	Bulk	BSE	Sell	93,299	₹64.99	₹0.61 Cr
29 Apr 2024	GLADISMENEZES	Bulk	BSE	Buy	15,000	₹59.95	₹0.09 Cr
6 Nov 2023	RAMESH LINGAMANENI	Bulk	BSE	Sell	17,694	₹195.65	₹0.35 Cr

1–10 of 50

1 / 5

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Arunjyoti Bio Ventures Ltd

Arunjyoti Bio Ventures Ltd

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

1

Announcements

1

Announcements

Annual reports

Not in the F&O segment

No fund holdings on record

Compounded sales growth

Stock price CAGR

Return on equity

Arunjyoti Bio Ventures Ltd

Arunjyoti Bio Ventures Ltd

About

Risk & technicals

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Ratios

Ratio timeline

Shareholding

Quarterly record

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

Stock splits1

Announcements

Stock splits1

Ratio timeline

Announcements

Annual reports

Quarterly record

Bulk & block deals

Board and management

Not in the F&O segment

No fund holdings on record

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Stock price CAGR

Return on equity

1

1